TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ANL

Adlai Nortye Ltd.

Healthcare · Biotechnology

15.10$ -4.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ANL
Line item 2019 2020 2021 2022 2023 2024 2025
– – -6.6% – -1,134.0% – -670.8%
– – 4.0% – 44.4% – 28.3%
– – 7.4% – 86.7% – 30.6%
– – -3.8% – – – –
– – 0.5% – 122.6% – -45.8%
– – 2.4% – 4.0% – 3.7%
– – -120.0% – -219.3% – -312.4%
– – 0.0% – 0.0% – 0.0%
– – -14.2% – 501.7% – -52.9%
– – 212.6% – 2,326.8% – -76.4%
– – 87.2% – 975.5% – -742.3%
– – -9.1% – -1,138.0% – -674.5%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?